-

Viz.ai Appoints Jallel Harrati as Chief Revenue Officer to Accelerate Enterprise Growth

Drawing on leadership experiences at Suki, IBM, and Philips, Harrati will help deepen the adoption of Viz.ai’s products across its health system partners

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the appointment of Jallel Harrati as Chief Revenue Officer (CRO). Harrati joins Viz.ai at an exciting stage as the company scales adoption of Viz Assist, its multimodal AI agent platform, across an established base of 2,000 hospitals.

Viz.ai has long been the leader in building and deploying AI Care Pathways that help ensure more patients receive guideline-based treatment, and hospitals increase clinical and financial efficiency. The recent addition of Viz Assist expands Viz.ai into helping doctors and clinical teams do their work. Viz Assist aims to help clinicians work faster, coordinate better, and focus more on patient care by delivering ambient listening, chart summaries, guideline assistance and coding recommendations in one seamless experience. In his role, Harrati will lead all revenue-generating functions for Viz.ai’s provider business, including sales, customer success, and sales operations.

“Jallel brings a rare combination of strategic vision, deep healthcare industry expertise, and a proven track record of scaling world-class commercial organizations,” said Chris Mansi, MD, CEO and co-founder of Viz.ai. “We are seeing accelerating demand for the broader Viz Platform, which helps reduce variability in care through our AI Care Pathways, and helps doctors and their teams do their work, through Viz Assist. It is a very exciting time to welcome such world class sales leadership to the company.”

Harrati comes to Viz.ai with more than 20 years of commercial leadership experience in healthcare and enterprise technology. Most recently, he served as SVP and GM of New Business Development at Suki. Over a six-year tenure, he built the commercial organization from the ground up and was instrumental in pioneering the market for AI-driven clinical solutions, scaling enterprise adoption across major health systems. Harrati also previously held senior leadership roles at IBM and Philips Healthcare, where he led sales and growth initiatives across AI, analytics, and provider-focused platforms.

“I’m joining Viz.ai at a moment of clear momentum,” said Harrati. “Viz.ai’s differentiated platform is delivering measurable value to health systems, clinicians, and patients, and Viz Assist creates an opportunity to standardize how care teams act on critical, real-time clinical insights. I’m excited to help scale this impact with this world-class team, accelerate growth and build a durable, category-leading business.”

Harrati’s appointment underscores Viz.ai’s focus on scaling its enterprise AI platform to transform clinical care in the hospital; reducing variability, improving outcomes, and reducing cost. With Viz Assist and a portfolio of over 50 AI Care Pathways and growing, Viz.ai is positioned as the defining agentic AI platform for healthcare.

About Viz.ai

Viz.ai is the leader in building and deploying AI-powered Care Pathways and helping doctors do their work. The Viz Platform is deployed in 2,000 hospitals across the United States and trusted by many of the leading life sciences companies. The platform uniquely combines real-time, multimodal clinical data with deep clinician engagement to detect disease earlier, coordinate care teams, and help ensure patients receive the right treatment faster. Viz.ai was the first company awarded CMS reimbursement for AI and is ranked the #1 Healthcare AI Platform by hospitals and health systems in the Black Book Research survey. For more information, visit Viz.ai.

Contacts

Media Contact
Caroline Rueve
viz.ai@solcomms.co

Viz.ai


Release Versions

Contacts

Media Contact
Caroline Rueve
viz.ai@solcomms.co

Social Media Profiles
More News From Viz.ai

Viz.ai and Salesforce Collaborate to Transform Pharma Engagement With Real-Time Clinical Intelligence for Agentforce

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of a new real-time clinical intelligence service for Salesforce’s Agentforce Life Sciences. These services will power new and existing agentic solutions for life sciences customers, including a data integration that will bring Viz.ai’s real-time data, triggers, and clinical intelligence layer from across a network of nearly 2,000 hospitals covering 230...

Viz.ai Closes 2025 with Record Scale and Patient Impact, Achieving Profitability in Its Healthcare Business while Accelerating Life Sciences Growth

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a milestone year marked by record growth in its provider footprint, profitability across its healthcare business, the launch of Viz Oncology and Viz Assist, and the doubling of its life sciences business over the past 18 months. Viz.ai is now adopted in nearly 2,000 hospitals across the United States, including the majority of the 50 largest health systems, suppo...

Viz.ai and NCCN Collaborate to Integrate NCCN Guidelines into Clinical Workflows for Oncologists

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced an agreement with the National Comprehensive Cancer Network® (NCCN®). This collaboration integrates NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Breast, Prostate, and Bladder Cancer into the Viz Oncology Platform making this important information readily available to clinicians when they’re making critical decisions about patient care. Thr...
Back to Newsroom